Skip to main content

Schizoaffective Disorder News (Page 3)

Avatar Therapy-Linked Emotions Identified in Treatment-Resistant Schizophrenia

FRIDAY, June 16, 2023 – The predominant emotions expressed by patients with treatment-resistant schizophrenia undergoing virtual reality-based Avatar therapy (AT) are mostly neutral, joy, and anger...

American Psychiatric Association, May 20-24

The annual meeting of the American Psychiatric Association was held from May 20 to 24 in San Francisco and attracted participants from around the world, including clinicians, academicians, allied...

FDA Medwatch Alert: Paliperidone Extended-Release Tablets 3mg by Teva Pharmaceuticals: Recall - Dissolution Test Failure

ISSUE: Teva Pharmaceuticals USA, Inc. (Teva) initiated a voluntary recall to retail-level on 05/31/2017 for one lot of Paliperidone Extended-Release Tablets, 3mg, 90 count bottles, lot 1160682A,...

FDA Approves sNDA for Invega Sustenna (paliperidone palmitate) for Schizoaffective Disorder

TITUSVILLE, N.J., Nov. 13, 2014 /PRNewswire/ – Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Applications (sNDAs)...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Schizophrenia

Related drug support groups

Prozac, Seroquel, Abilify, fluoxetine, lithium, lamotrigine, quetiapine, olanzapine, risperidone, view more... Risperdal, aripiprazole, Seroquel XR, Geodon, Invega, Tegretol, Invega Sustenna